Jazz Pharmaceuticals
ISIN IE00B4Q5ZN47
|WKN A1JS1K
| Is 2025 your year to invest? Explore Invesco ETFs. Capital at risk. Overview
Quote
Description
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals Ireland
Chart
Financials
Key metrics
| Market capitalisation, EUR | 7,197.99 m |
| EPS, EUR | 6.41 |
| P/B ratio | 1.78 |
| P/E ratio | 17.74 |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 3,546.58 m |
| Net income, EUR | 383.71 m |
| Profit margin | 10.82% |
What ETF is Jazz Pharmaceuticals in?
There are 36 ETFs which contain Jazz Pharmaceuticals. All of these ETFs are listed in the table below. The ETF with the largest weighting of Jazz Pharmaceuticals is the L&G Pharma Breakthrough UCITS ETF.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc) | 0.13% | Equity United States Small Cap | 1,369 | 0.14% | 56 | +24.11% | A3DQ08 | IE000JNKVS10 |
| Amundi MSCI World IMI Value Screened Factor UCITS ETF UCITS ETF Acc | 0.10% | Equity World Value Climate Change | 335 | 0.25% | - | - | ETF212 | IE000AZV0AS3 |
| Amundi MSCI World Small Cap Screened CTB UCITS ETF UCITS ETF Acc | 0.06% | Equity World Small Cap Climate Change | 823 | 0.25% | - | - | ETF218 | IE000UZZ5D45 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to EUR) A-acc | 0.02% | Equity United States Multi-Factor Strategy | 1,924 | 0.28% | 7 | +14.46% | A2DWAC | IE00BDGV0746 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.13% | Equity United States Small Cap | 1,369 | 0.14% | 167 | +23.60% | A3DQ09 | IE0001O84583 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-dis | 0.02% | Equity United States Multi-Factor Strategy | 1,924 | 0.25% | 33 | +25.77% | A2DND0 | IE00BDGV0308 |
| L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0.48% | Equity World Social/Environmental Innovation | 367 | 0.60% | 4 | +11.43% | A3DHPA | IE000VTOHNZ0 |
| L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing | 0.01% | Equity World Multi-Factor Strategy | 3,650 | 0.50% | 68 | +19.77% | WELT0B | IE000FPWSL69 |
| UBS ETF (IE) MSCI USA Small Cap ESG Leaders UCITS ETF (USA) A-acc | 0.28% | Equity United States Small Cap | 712 | 0.20% | 580 | - | A40EWV | IE000XFXBGR0 |
| iShares MSCI World Small Cap UCITS ETF | 0.08% | Equity World Small Cap | 3,321 | 0.35% | 4,730 | +15.73% | A2DWBY | IE00BF4RFH31 |
| Xtrackers MSCI Global SDG 3 Good Health UCITS ETF 1C | 0.22% | Equity World Health Care Social/Environmental | 115 | 0.35% | 78 | +8.36% | DBX0SM | IE00036F4K40 |
| HSBC MSCI USA UCITS ETF USD | 0.02% | Equity United States | 620 | 0.30% | 41 | +31.36% | A1CY1Q | IE00B5WFQ436 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Accumulating | 0.01% | Equity North America Social/Environmental | 1,442 | 0.12% | 254 | +30.49% | A3DJRE | IE000O58J820 |
| Xtrackers World Small Cap Green Transition Innovators UCITS ETF 1C | 1.40% | Equity World Small Cap Innovation | 180 | 0.45% | 2 | - | DBX0V9 | LU2859297330 |
| Xtrackers MSCI Global SDGs Social Fairness Contributors UCITS ETF 1C | 0.04% | Equity World Social/Environmental | 226 | 0.35% | 3 | - | DBX0UT | IE000L2IS494 |
| SPDR MSCI ACWI IMI UCITS ETF USD Unhedged (Acc) | 0.04% | Equity World | 3,660 | 0.17% | 2,275 | +23.01% | A1JJTD | IE00B3YLTY66 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-acc | 0.02% | Equity United States Multi-Factor Strategy | 1,924 | 0.25% | 83 | +25.71% | A2JSD1 | IE00BDGV0415 |
| SPDR MSCI World Small Cap UCITS ETF | 0.08% | Equity World Small Cap | 3,528 | 0.45% | 900 | +16.14% | A1W56P | IE00BCBJG560 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% | Equity World Social/Environmental | 5,774 | 0.24% | 410 | +23.76% | A2QL8V | IE00BNG8L385 |
| Invesco Nasdaq Next Generation 100 UCITS ETF Acc | 0.48% | Equity United States Technology | 101 | 0.25% | 44 | +27.48% | A2QPVX | IE00BMD8KP97 |
| SPDR MSCI ACWI IMI UCITS ETF USD Unhedged (Dist) | 0.04% | Equity World | 3,660 | 0.17% | 17 | - | A40F93 | IE000DD75KQ5 |
| UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (hedged to CHF) A-acc | 0.02% | Equity United States Multi-Factor Strategy | 1,924 | 0.28% | 23 | +10.84% | A2DWAB | IE00BDGV0C91 |
| iShares MSCI USA Small Cap ESG Enhanced UCITS ETF (Acc) | 0.14% | Equity United States Small Cap | 1,604 | 0.43% | 2,283 | +20.28% | A0X8SB | IE00B3VWM098 |
| Xtrackers MSCI Global SDGs UCITS ETF 1C | 0.14% | Equity World Social/Environmental | 227 | 0.35% | 10 | +0.58% | DBX0SL | IE000PSF3A70 |
| iShares Russell 1000 Value UCITS ETF USD (Acc) | 0.03% | Equity United States Value | 847 | 0.18% | 85 | +21.96% | A3ECC2 | IE0002EKOXU6 |
| Invesco FTSE RAFI US 1000 UCITS ETF | 0.02% | Equity United States Fundamental/Quality | 1,006 | 0.39% | 406 | +24.20% | A0M2EA | IE00B23D8S39 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.77% | Equity United States Health Care Biotech | 212 | 0.35% | 30 | +2.30% | A2JDYM | IE00BDZVHG35 |
| L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating | 0.01% | Equity World Multi-Factor Strategy | 3,650 | 0.50% | 369 | +20.37% | WELT0A | IE0001UQQ933 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.77% | Equity United States Health Care Biotech | 212 | 0.35% | 430 | +2.88% | A2DWAW | IE00BYXG2H39 |
| SPDR MSCI USA Small Cap Value Weighted UCITS ETF | 0.10% | Equity United States Small Cap | 1,737 | 0.30% | 563 | +20.18% | A12HU5 | IE00BSPLC413 |
| SPDR S&P 400 US Mid Cap UCITS ETF | 0.24% | Equity United States Mid Cap | 401 | 0.30% | 4,478 | +22.99% | A1JSHV | IE00B4YBJ215 |
| iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc) | 0.09% | Equity World Small Cap | 2,531 | 0.35% | 59 | +15.22% | A3C14G | IE000T9EOCL3 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.01% | Equity North America Social/Environmental | 1,442 | 0.12% | 29 | +30.60% | A3DJRF | IE000L2ZNB07 |
| HSBC MSCI World Small Cap ESG UCITS ETF USD (Acc) | 0.17% | Equity World Small Cap | 1,149 | 0.25% | 59 | +14.38% | A3DUNV | IE000C692SN6 |
| Vanguard ESG Global All Cap UCITS ETF (USD) Accumulating | 0.01% | Equity World Social/Environmental | 5,774 | 0.24% | 459 | +24.00% | A2QL8U | IE00BNG8L278 |
| L&G Pharma Breakthrough UCITS ETF | 3.06% | Equity World Health Care Innovation | 37 | 0.49% | 17 | +0.83% | A2H9XR | IE00BF0H7608 |
Performance
Returns overview
| YTD | +4.62% |
| 1 month | +3.80% |
| 3 months | +21.40% |
| 6 months | +24.39% |
| 1 year | +8.39% |
| 3 years | -3.49% |
| 5 years | - |
| Since inception (MAX) | +15.39% |
| 2024 | -0.27% |
| 2023 | -25.97% |
| 2022 | +34.27% |
| 2021 | -17.56% |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 28.22% |
| Volatility 3 years | 27.52% |
| Volatility 5 years | - |
| Return per risk 1 year | 0.30 |
| Return per risk 3 years | -0.04 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -24.93% |
| Maximum drawdown 3 years | -42.69% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -42.69% |
Rolling 1 year volatility
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.